Navigation Links
Global Cancer Diagnostics Market to Witness Robust Growth, According to VPG Report Published at MarketPublishers.com
Date:9/27/2013

London, UK (PRWEB) September 27, 2013

At present, the world cancer diagnostics industry is on the threshold of technological breakthrough, supported by ongoing advancements in tumor diagnosis and therapy, introduction of new specific antigens and advances in research on cancer’s genetic basis. The world cancer diagnostics market is forecast to experience tremendous growth and rapid expansion in the next five years. Expected technological developments in the industry are likely to open many new opportunities in cancer diagnostics, enabling to determine genetic predispositions, detect specific tumors and monitor biological responses to cancer treatment. The rapid market expansion and growing demand for malignancy assays is expected to be spurred by the increase in the elderly population.

Abbott, Becton Dickinson, Epigenomics, Applied Gene Technologies, Panacea Pharmaceuticals, Myriad Genetics and Enzo Biochem are amid the leading companies which are currently active in the global cancer diagnostics market.

In-demand research report “Global Cancer Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies” worked out by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Cancer Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
Published: August, 2013
Pages: 1200
Price:    US$ 32,500.00
http://marketpublishers.com/report/diagnostics-diseases/cancer/global-cancer-diagnostics-market-2013-france-germany-italy-japan-spain-uk-usa-sales-forecasts-supplier-shares-competitive-strategies.html

The report provides an in-depth analysis of the cancer diagnostics market with a focus on France, Germany, Italy, Japan, Spain, the UK and the US. It discloses critical information on the market size and performance, delves into the competitive landscape, and uncovers details on the leading players in the field. The study presents a comprehensive market assessment by geography and tests; contains sales and market share analyses; examines the main trends in the sector. The research study evaluates the market opportunities, reviews potential market entry barriers and risks as well as suggests alternative business expansion strategies for suppliers, covers current and emerging products, analyzes potential applications of various diagnostic technologies. Moreover, the report includes sales forecasts for the major tumor markers.

Report Scope:

  •     Extensive overview of the worldwide cancer diagnostics market.
  •     In-depth analysis of seven country markets (France, Germany, Italy, Japan, Spain, the UK and the US).
  •     Review of the current and emerging products along with analysis of potential application of various diagnostic technologies.
  •     Discussion of the trends prevailing in the market.
  •     Essential data on the market size and structure.
  •     Examination of the competitive environment and comprehensive profiles of the leading companies.
  •     Discussion of the alternative market penetration strategies.
  •     Evaluation of the potential market entry barriers and risks.
  •     Alternative business expansion strategies for suppliers.
  •     Sales forecast for the major tumor markers.

More insightful research reports by the publisher can be found at VPG page.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11171596.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 15, 2017 After spending the past two years building ... data collection, GeneFo now offers this platform to healthcare stakeholders (hospitals, ... support, adherence, and data collection vis a vis their members, under ... successful launch of this offer. ... GeneFo ...
(Date:8/15/2017)... San Diego, CA (PRWEB) , ... August 15, ... ... science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the ... reduces the number of steps needed to gain kinetic binding data for a ...
(Date:8/15/2017)... , ... August 15, 2017 , ... Any expert in ... has compromised these disciplines for more than half a century. Despite their essential ... It is widely known that molecular tags developed for this purpose also tag ...
(Date:8/15/2017)... , ... August 15, 2017 , ... The Conference ... on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The ... 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our experience ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):